US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist

12.040
-0.560-4.44%

Trading May 23 14:43 ET

976.22MMarket Cap-15050P/E (TTM)

Verona Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-135.39%-13.61M

16.10%-50.22M

-34.43%-10.4M

29.67%-12.73M

-9.19%-21.31M

60.16%-5.78M

-80.01%-59.86M

55.33%-7.74M

-179.28%-18.1M

3.41%-19.52M

Net income from continuing operations

-54.06%-25.79M

20.86%-54.37M

-35.22%-14.13M

6.14%-14.69M

50.43%-8.81M

32.59%-16.74M

-23.63%-68.7M

55.07%-10.45M

-241.59%-15.65M

19.49%-17.77M

Operating gains losses

123.50%219K

-140.28%-1.87M

51.23%-1.21M

-73.71%1.01M

-134.63%-740K

-183.29%-932K

126.59%4.63M

84.28%-2.47M

448.29%3.85M

177.94%2.14M

Depreciation and amortization

67.52%263K

6.45%677K

37.75%208K

-1.27%155K

-4.85%157K

-3.68%157K

1.11%636K

-6.79%151K

-3.09%157K

8.55%165K

Other non cash items

89.01%172K

18.09%222K

29.63%35K

-11.11%48K

-9.43%48K

68.52%91K

-21.34%188K

-49.06%27K

0.00%54K

-35.37%53K

Change In working capital

-1.13%7.27M

-29.43%-13.9M

-75.40%124K

53.52%-4.33M

-138.06%-17.04M

40.34%7.36M

-179.87%-10.74M

-97.08%504K

-257.55%-9.32M

-132.51%-7.16M

-Change in receivables

74.71%-585K

-127.85%-1.1M

-107.91%-1.03M

111.69%310K

139.59%1.93M

-46.58%-2.31M

157.25%3.96M

21.61%13.08M

-109.41%-2.65M

88.86%-4.88M

-Change in prepaid assets

-100.53%-5K

-172.69%-1.12M

-133.29%-285K

-277.18%-2.44M

119.14%667K

-66.39%938K

206.99%1.54M

-67.51%856K

-56.25%1.38M

-35.60%-3.49M

-Change in payables and accrued expense

-19.57%6.77M

29.73%-10.9M

89.49%-1.51M

74.98%-1.76M

-1,557.35%-16.06M

78.03%8.42M

-172.49%-15.51M

-359.40%-14.33M

-172.33%-7.01M

-86.51%1.1M

-Change in other current assets

-30.84%942K

158.64%777K

7,492.50%3.04M

80.03%-244K

-1,158.93%-3.38M

394.81%1.36M

-69.22%-1.33M

103.95%40K

-121.62%-1.22M

105.64%319K

-Change in other current liabilities

114.18%149K

-358.93%-1.55M

-110.20%-88K

-210.70%-207K

3.30%-205K

-339.75%-1.05M

179.65%599K

237.20%863K

126.79%187K

-127.53%-212K

Cash from discontinued investing activities

Operating cash flow

-135.39%-13.61M

16.10%-50.22M

-34.43%-10.4M

29.67%-12.73M

-9.19%-21.31M

60.16%-5.78M

-80.01%-59.86M

55.33%-7.74M

-179.28%-18.1M

3.41%-19.52M

Investing cash flow

Cash flow from continuing investing activities

-16K

-141.67%-29K

-29K

Net PPE purchase and sale

---16K

--0

-141.67%-29K

--0

---29K

Cash from discontinued investing activities

Investing cash flow

---16K

--0

-141.67%-29K

--0

---29K

Financing cash flow

Cash flow from continuing financing activities

-104.55%-3.12M

-34.05%92.87M

818.59%24.01M

-99.97%48K

118.00%124K

9,560.74%68.69M

2,402.08%140.82M

390.12%2.61M

7,784.04%139.62M

79.73%-689K

Net issuance payments of debt

--0

674.16%38.71M

474.24%28.71M

--0

--10M

--5M

--0

Net common stock issuance

--0

-62.01%56.91M

--0

--47K

84,768.66%56.86M

20,336.15%149.8M

--0

42,680.00%149.73M

--0

Proceeds from stock option exercised by employees

-55.34%816K

42.06%1.95M

-100.30%-3K

-87.06%48K

--77K

--1.83M

--1.37M

--1M

--371K

--0

Net other financing activities

---3.94M

69.40%-4.7M

----

-124.10%-15.35M

-275.92%-3.39M

-383.71%-10.48M

---689K

Cash from discontinued financing activities

Financing cash flow

-104.55%-3.12M

-34.05%92.87M

818.59%24.01M

-99.97%48K

118.00%124K

9,560.74%68.69M

2,402.08%140.82M

390.12%2.61M

7,784.04%139.62M

79.73%-689K

Net cash flow

Beginning cash position

19.29%271.77M

53.54%227.83M

11.08%257.37M

142.78%270.73M

119.50%291.42M

53.54%227.83M

-21.07%148.38M

39.12%231.7M

-23.64%111.51M

-21.72%132.76M

Current changes in cash

-126.63%-16.75M

-47.30%42.65M

365.61%13.61M

-110.43%-12.68M

-4.70%-21.19M

512.80%62.9M

305.49%80.93M

71.88%-5.12M

478.77%121.52M

14.27%-20.24M

Effect of exchange rate changes

-120.58%-141K

187.70%1.3M

-36.32%796K

48.84%-682K

148.97%499K

281.22%685K

-563.68%-1.48M

2,055.17%1.25M

-174.85%-1.33M

-2,585.37%-1.02M

End cash Position

-12.54%254.88M

19.29%271.77M

11.08%257.37M

142.78%270.73M

119.50%291.42M

53.54%227.83M

39.12%231.7M

-23.64%111.51M

Free cash flow

-135.66%-13.63M

16.14%-50.22M

-34.43%-10.4M

29.67%-12.73M

-9.03%-21.31M

60.16%-5.78M

-80.04%-59.89M

55.33%-7.74M

-179.32%-18.1M

3.26%-19.55M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-135.39%-13.61M	16.10%-50.22M	-34.43%-10.4M	29.67%-12.73M	-9.19%-21.31M	60.16%-5.78M	-80.01%-59.86M	55.33%-7.74M	-179.28%-18.1M	3.41%-19.52M
Net income from continuing operations	-54.06%-25.79M	20.86%-54.37M	-35.22%-14.13M	6.14%-14.69M	50.43%-8.81M	32.59%-16.74M	-23.63%-68.7M	55.07%-10.45M	-241.59%-15.65M	19.49%-17.77M
Operating gains losses	123.50%219K	-140.28%-1.87M	51.23%-1.21M	-73.71%1.01M	-134.63%-740K	-183.29%-932K	126.59%4.63M	84.28%-2.47M	448.29%3.85M	177.94%2.14M
Depreciation and amortization	67.52%263K	6.45%677K	37.75%208K	-1.27%155K	-4.85%157K	-3.68%157K	1.11%636K	-6.79%151K	-3.09%157K	8.55%165K
Other non cash items	89.01%172K	18.09%222K	29.63%35K	-11.11%48K	-9.43%48K	68.52%91K	-21.34%188K	-49.06%27K	0.00%54K	-35.37%53K
Change In working capital	-1.13%7.27M	-29.43%-13.9M	-75.40%124K	53.52%-4.33M	-138.06%-17.04M	40.34%7.36M	-179.87%-10.74M	-97.08%504K	-257.55%-9.32M	-132.51%-7.16M
-Change in receivables	74.71%-585K	-127.85%-1.1M	-107.91%-1.03M	111.69%310K	139.59%1.93M	-46.58%-2.31M	157.25%3.96M	21.61%13.08M	-109.41%-2.65M	88.86%-4.88M
-Change in prepaid assets	-100.53%-5K	-172.69%-1.12M	-133.29%-285K	-277.18%-2.44M	119.14%667K	-66.39%938K	206.99%1.54M	-67.51%856K	-56.25%1.38M	-35.60%-3.49M
-Change in payables and accrued expense	-19.57%6.77M	29.73%-10.9M	89.49%-1.51M	74.98%-1.76M	-1,557.35%-16.06M	78.03%8.42M	-172.49%-15.51M	-359.40%-14.33M	-172.33%-7.01M	-86.51%1.1M
-Change in other current assets	-30.84%942K	158.64%777K	7,492.50%3.04M	80.03%-244K	-1,158.93%-3.38M	394.81%1.36M	-69.22%-1.33M	103.95%40K	-121.62%-1.22M	105.64%319K
-Change in other current liabilities	114.18%149K	-358.93%-1.55M	-110.20%-88K	-210.70%-207K	3.30%-205K	-339.75%-1.05M	179.65%599K	237.20%863K	126.79%187K	-127.53%-212K
Cash from discontinued investing activities
Operating cash flow	-135.39%-13.61M	16.10%-50.22M	-34.43%-10.4M	29.67%-12.73M	-9.19%-21.31M	60.16%-5.78M	-80.01%-59.86M	55.33%-7.74M	-179.28%-18.1M	3.41%-19.52M
Investing cash flow
Cash flow from continuing investing activities	-16K	0	0	0	0	0	-141.67%-29K	0	0	-29K
Net PPE purchase and sale	---16K	--0	--0	--0	--0	--0	-141.67%-29K	--0	--0	---29K
Cash from discontinued investing activities
Investing cash flow	---16K	--0	--0	--0	--0	--0	-141.67%-29K	--0	--0	---29K
Financing cash flow
Cash flow from continuing financing activities	-104.55%-3.12M	-34.05%92.87M	818.59%24.01M	-99.97%48K	118.00%124K	9,560.74%68.69M	2,402.08%140.82M	390.12%2.61M	7,784.04%139.62M	79.73%-689K
Net issuance payments of debt	--0	674.16%38.71M	474.24%28.71M	--0	--0	--10M	--5M	--5M	--0	--0
Net common stock issuance	--0	-62.01%56.91M	--0	--0	--47K	84,768.66%56.86M	20,336.15%149.8M	--0	42,680.00%149.73M	--0
Proceeds from stock option exercised by employees	-55.34%816K	42.06%1.95M	-100.30%-3K	-87.06%48K	--77K	--1.83M	--1.37M	--1M	--371K	--0
Net other financing activities	---3.94M	69.40%-4.7M	----	----	----	----	-124.10%-15.35M	-275.92%-3.39M	-383.71%-10.48M	---689K
Cash from discontinued financing activities
Financing cash flow	-104.55%-3.12M	-34.05%92.87M	818.59%24.01M	-99.97%48K	118.00%124K	9,560.74%68.69M	2,402.08%140.82M	390.12%2.61M	7,784.04%139.62M	79.73%-689K
Net cash flow
Beginning cash position	19.29%271.77M	53.54%227.83M	11.08%257.37M	142.78%270.73M	119.50%291.42M	53.54%227.83M	-21.07%148.38M	39.12%231.7M	-23.64%111.51M	-21.72%132.76M
Current changes in cash	-126.63%-16.75M	-47.30%42.65M	365.61%13.61M	-110.43%-12.68M	-4.70%-21.19M	512.80%62.9M	305.49%80.93M	71.88%-5.12M	478.77%121.52M	14.27%-20.24M
Effect of exchange rate changes	-120.58%-141K	187.70%1.3M	-36.32%796K	48.84%-682K	148.97%499K	281.22%685K	-563.68%-1.48M	2,055.17%1.25M	-174.85%-1.33M	-2,585.37%-1.02M
End cash Position	-12.54%254.88M	19.29%271.77M	19.29%271.77M	11.08%257.37M	142.78%270.73M	119.50%291.42M	53.54%227.83M	53.54%227.83M	39.12%231.7M	-23.64%111.51M
Free cash flow	-135.66%-13.63M	16.14%-50.22M	-34.43%-10.4M	29.67%-12.73M	-9.03%-21.31M	60.16%-5.78M	-80.04%-59.89M	55.33%-7.74M	-179.32%-18.1M	3.26%-19.55M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall